)
)
Nonacus
Stand: C40
Nonacus focuses on liquid biopsy and
Next Generation Sequencing (NGS) technologies to improve cancer diagnosis,
offering hereditary cancer testing services and GALEAS Bladder, a sensitive,
non-invasive urine test for detection and monitoring.